👀Openevidence also an M&A target, reaching $300m annualized revenue
Yes I too totally hate when a round would dilute shareholders 1%
AI applications startups still going strong among VCs. OpenEvidence is getting inbound offers at $20B, last valued at $12B Also becomes an M&A target🎯 @steph_palazzolo
Users in the replies dismiss OpenEvidence's reported $20B valuation raise and M&A interest as unrealistic, arguing that demand for the round must actually be very low.
Based on 1 visible X reactions from 3 accounts; directional sample.
Ask a question below.
Published answers will appear here.
@amir demand must be very low for the round
Yes I too totally hate when a round would dilute shareholders 1%
👀Openevidence also an M&A target, reaching $300m annualized revenue
Users in the replies dismiss OpenEvidence's reported $20B valuation raise and M&A interest as unrealistic, arguing that demand for the round must actually be very low.
Based on 1 visible X reactions from 3 accounts; directional sample.
Ask a question below.
Published answers will appear here.
